Last reviewed · How we verify
Non-steroidal anti-inflammatory drug — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Non-steroidal anti-inflammatory drug (Non-steroidal anti-inflammatory drug) — Sucampo Pharma Americas, LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Non-steroidal anti-inflammatory drug TARGET | Non-steroidal anti-inflammatory drug | Sucampo Pharma Americas, LLC | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Non-steroidal anti-inflammatory drug CI watch — RSS
- Non-steroidal anti-inflammatory drug CI watch — Atom
- Non-steroidal anti-inflammatory drug CI watch — JSON
- Non-steroidal anti-inflammatory drug alone — RSS
Cite this brief
Drug Landscape (2026). Non-steroidal anti-inflammatory drug — Competitive Intelligence Brief. https://druglandscape.com/ci/non-steroidal-anti-inflammatory-drug. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab